Recall of a defective batch of Implanon implant containing Etonogestrel

SOL Limited (Singapore Branch), a subsidiary of Merck & Co., is recalling all unused units of Implanon units from batch No.: 476471/434216 with effect from 2 July 2010 due to a manufacturing defect that lead to increased resistance in retracting the applicator cannula. The product defect is a mechanical deficiency in the applicator and has no effect on the implant itself. In the affected units, difficulties or inconvenience may be experienced during the insertion procedure. The risk to patient is assessed to be minimal. Prescribers are advised to immediately cease the use of this affected batch. Arrangements will be made by the company for the replacement of the Implanon units from the defective batch.

 
 
Healthcare professional, Therapeutic Products
Published:

Dear Healthcare Professional Letters

12 Dec 2019

Only abstracts of the Dear Healthcare Professional Letters (DHCPL) are provided on this website. Details of the letters can be found on the MOH Alert System, which is accessible via the Health Professionals Portal (HPP). HPP is a one-stop portal for all healthcare professionals in Singapore. Dentists, medical doctors and pharmacists may access HPP at https://www.hpp.moh.gov.sg/, and follow the procedures below to access the MOH Alert system.

Step 1: Scroll down to the bottom navigation panel of the HPP web page. Under the Healthcare Professionals section, expand the dropdown option for ‘Healthcare Professional Portal’ and select your profession. You will be redirected to the specific HPP web page to log in.

Step 2: Click on the Restricted Content icon on the left panel of the web page and log in via SingPass.

Step 3: Click on the MOH Alert icon under the ‘Applications’ section.

Step 4: Click on the Drug Alert tab to view the DHCPLs.